Article
Interplay in the selection of fluoroquinolone resistance and bacterial fitness.
PLoS pathogens - 1 Aug 2009
Marcusson Linda L, Frimodt-Møller Niels, Hughes Diarmaid
Abstract excerpt
Fluoroquinolones are antibacterial drugs that inhibit DNA Gyrase and Topoisomerase IV. These essential enzymes facilitate chromosome replication and RNA transcription by regulating chromosome supercoiling. High-level resistance to fluoroquinolones in E. coli requires the accumulation of multiple mutations, including those that alter target genes and genes regulating drug efflux. Previous studies have shown some...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
